|
Market Cap (5-Jun) $102,067,456 (1,050th) |
Close (30-Jun) $0.062 |
Volume (30-Jun) 526,676 |
Shortsold (26-May) 683,172 (0.11%) (444th) |
|
52w High $0.67 |
52w Low $0.165 |
P/E 10.78 |
EPS -0.03 |
DXB released this announcement to the ASX on 24 February 2022, 9:57. The announcement is not marked as price sensitive, and is 25 page(s) in length and 4.85MB in size.
You can view all announcements from DXB and see how they appear on a price chart on the announcements page.
At the date of this announcement, DXB was 0.002% short sold according to ASIC data. It was ranked the 680th most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from DXB | |
|---|---|
| Application for quotation of securities - DXB | 29 June 2023, 9:01 |
| Application for quotation of securities - DXB | 29 June 2023, 9:00 |
| Application for quotation of securities - DXB | 29 June 2023, 8:59 |
| Investor Presentation | 24 February 2022, 9:57 |
| Half-Year Financial Report & Appendix 4D - 31 December 2021 | 24 February 2022, 9:24 |
| Dimerix Appoints Chief Medical Officer | 7 February 2022, 10:46 |
| First Regulatory Approval in Europe for DMX-200 FSGS Study | 1 February 2022, 11:50 |
You must be logged in to post a reply.
Dimerix 